Algert Global’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.56M | Buy |
1,021,280
+136,680
| +15% | +$1.28M | 0.2% | 140 |
|
2025
Q1 | $10.9M | Buy |
884,600
+98,968
| +13% | +$1.22M | 0.27% | 82 |
|
2024
Q4 | $10.4M | Buy |
785,632
+310,634
| +65% | +$4.11M | 0.24% | 99 |
|
2024
Q3 | $9.14M | Buy |
474,998
+42,870
| +10% | +$825K | 0.25% | 95 |
|
2024
Q2 | $8.87M | Buy |
432,128
+6,455
| +2% | +$133K | 0.3% | 61 |
|
2024
Q1 | $10.1M | Sell |
425,673
-102,484
| -19% | -$2.44M | 0.4% | 35 |
|
2023
Q4 | $11.4M | Buy |
528,157
+71,938
| +16% | +$1.55M | 0.46% | 13 |
|
2023
Q3 | $6.62M | Buy |
456,219
+202,588
| +80% | +$2.94M | 0.31% | 67 |
|
2023
Q2 | $5.31M | Buy |
253,631
+167,660
| +195% | +$3.51M | 0.23% | 104 |
|
2023
Q1 | $1.82M | Buy |
85,971
+8,191
| +11% | +$173K | 0.09% | 381 |
|
2022
Q4 | $1.98M | Buy |
77,780
+28,880
| +59% | +$735K | 0.11% | 300 |
|
2022
Q3 | $1.18M | Sell |
48,900
-5,814
| -11% | -$140K | 0.07% | 471 |
|
2022
Q2 | $1.05M | Buy |
54,714
+13,180
| +32% | +$254K | 0.08% | 448 |
|
2022
Q1 | $722K | Buy |
41,534
+9,948
| +31% | +$173K | 0.05% | 666 |
|
2021
Q4 | $691K | Buy |
+31,586
| New | +$691K | 0.09% | 420 |
|
2021
Q2 | – | Sell |
-9,550
| Closed | -$214K | – | 520 |
|
2021
Q1 | $214K | Sell |
9,550
-18,020
| -65% | -$404K | 0.07% | 366 |
|
2020
Q4 | $613K | Buy |
27,570
+8,440
| +44% | +$188K | 0.17% | 191 |
|
2020
Q3 | $282K | Buy |
19,130
+8,350
| +77% | +$123K | 0.09% | 268 |
|
2020
Q2 | $160K | Sell |
10,780
-11,800
| -52% | -$175K | 0.05% | 346 |
|
2020
Q1 | $248K | Sell |
22,580
-3,000
| -12% | -$33K | 0.1% | 278 |
|
2019
Q4 | $225K | Buy |
25,580
+8,110
| +46% | +$71.3K | 0.07% | 300 |
|
2019
Q3 | $131K | Buy |
17,470
+1,600
| +10% | +$12K | 0.05% | 308 |
|
2019
Q2 | $148K | Buy |
+15,870
| New | +$148K | 0.05% | 302 |
|
2018
Q3 | – | Sell |
-73,499
| Closed | -$516K | – | 382 |
|
2018
Q2 | $516K | Buy |
+73,499
| New | +$516K | 0.11% | 241 |
|